L.H. Utidjian1,3; A. Hogan1; J. Michel3; A.R. Localio2; D. Karavite3; L.Song4; M.J. Ramos3; A.G. Fiks1,3; S.Lorch1; R.W. Grundmeier1,3 1Departments of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; 2Departments of Biostatics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; 3Depart...

1 Epidemiology, Clinical Presentation and Therapy.......... 19 1.1 Classification ......................................................................... 20 1.2 Epidemiology......................................................................... 20 1.3 Clinical Presentation.............................................................. 20 1.4 Therapy .............................................

1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden 2 Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark 3 Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden 4 Department of Clinical Immunology, Odense University Hospital, Odense, Denmark 5 Department of Medicine...

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1412 1. Respiratory Syncytial Virus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1413 1.1 Epidemiology . . . . . . . . . . . . . . . . . . . . . . . ....

Tuberculous myocarditis is a very unusual manifestation of tuberculosis.Our case serves to highlight potentially life threating and rare presentation tuberculosis.We discuss here the epidemiology,clinical , diagnostic approach management myocardial tuberculosis.

C hronic diseases have become an increasing portion of modern medicine in the Western world and the goals for treatment are not only to relieve symptoms and their influence on daily life for patients but also to avoid long term complications of the disease and of the treatment given. The rules for obtaining evidence of the benefit of a new treatment have been widely accepted, with the randomise...

problem Epidemiology Cholangiocarcinoma (CCA) is the second most common primary liver cancer globally, and the most common cause of death from primary liver cancer in the United Kingdom, where it kills 1500 people annually (Khan et al., 2012). At diagnosis, 65% of cases of CCA are in individuals who are over 65 years old, and the disease occurs equally in men and women. Globally, CCA incidence ...

1 Department of Epidemiology and Biostatistics, Faculty of Medicine, McGill University, Montreal, Quebec, Canada. 2 Division of Clinical Epidemiology, Montreal General Hospital, Montreal, Quebec, Canada. 3 Department of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada. 4 Division of Clinical Epidemiology, Royal Victoria Hospital, Montreal, Quebec, Canada. 5 Division of...